Claim OwnershipJSCAI BEATS
Subscribed: 3Played: 10
Subscribe
© The Journal of the Society for Cardiovascular Angiography & Interventions
Description
Interventional Cardiology experts explore the latest breakthroughs, insights, and exclusive interviews from The Journal of the Society for Cardiovascular Angiography and Interventions (JSCAI), SCAI's official journal. Stay connected with your on-the-go journal resource for the latest cutting-edge developments, innovations, and research.
108 Episodes
Reverse
This interview with Drs Sandeep Nathan, Suzanne Baron, Mir B. Basir, Mirvat Alasnag highlight the consensus statement addressing sex-based disparities in cardiogenic shock care. Experts discuss the current state of treatment for women, gaps in evidence, and priorities for improving outcomes, offering practical insights and guidance for practice. Read the article published in JSCAI: https://www.jscai.org/article/S2772-9303(24)01373-5/fulltext
This conversation explores a nationwide Swedish study comparing Absorb bioresorbable scaffolds to drug-eluting stents in over 1,900 patients. While early complications were higher with scaffolds, long-term results suggest potential benefits including lower heart attack rates after three years.SCAI Experts, Drs. Dean Kereiakes, Saman Saidi-Seresht, Patrick Serruys, and Gregg Stone discuss the highlights from this original research article. Read the JSCAI article: https://doi.org/10.1016/j.jscai.2025.103724
The global Optimize PRO study shows that using a standardized TAVR care pathway and cusp overlap technique with Evolut PRO/PRO+ valves led to low pacemaker rates, no moderate/severe aortic regurgitation, and favorable 30-day outcomes. SCAI Experts, Drs. Suzanne Baron, Steven Yakubov, John Forrest, and Mayra Guerrero discuss the highlights from this original research article. Read the JSCAI article: https://doi.org/10.1016/j.jscai.2025.103515
Drs. Sahil Parikh, Robert Attaran, Pamela Kim, and Jeff Carr discuss the newly released SCAI guidelines on chronic venous disease (CVD), highlighting key takeaways from the comprehensive review. They discuss the clinical rationale behind the evidence-based recommendations, including guidance on compression therapy, vein ablation, and revascularization strategies. The panel also explores the decision-making algorithms developed to streamline treatment and areas where further research is urgently needed.Read the JSCAI article: https://doi.org/10.1016/j.jscai.2025.103729
Yiannis Chatzizisis, Guest Editor of JSCAI's Special Issue on The Role of AI in Cardiovascular Interventions, moderates this interview exploring the intersection of interventional cardiology (IC) training, education, and artificial intelligence. The discussion centers around three featured papers from the special issue, authored by Drs. Saurav Chatterjee, Saumya Nanda, Amanda DeVos, and Trevor Simard, each highlighting innovative applications of AI in the education and training of cardiovascular specialists:1- Evaluating AI's Ability to Address Nuanced Cardiology Subspecialty Questions: ChatGPT and CathSAPhttps://doi.org/10.1016/j.jscai.2025.1025632- Development of an Educational Application of Multi-modal Imaging of Clinically Implanted and Bifurcation Stenting Procedureshttps://doi.org/10.1016/j.jscai.2024.1024993- Virtual Reality Simulation with Integrated Passive Haptics Prototype for Cardiac Catheterization Laboratory Traininghttps://doi.org/10.1016/j.jscai.2024.102451
Experts, Sahil Parikh, Abdullah Shaikh, Steven Abramowitz, and Hillary Johnston-Cox discuss this study published in JSCAI, highlighting its contribution to the evolving management of venous in-stent thrombosis. This multicenter retrospective analysis evaluated the safety and feasibility of the RevCore thrombectomy catheter, demonstrating technical success with no device-related serious adverse events and 94% patency at first follow-up.Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2025.102571
Beginning in the late 1970s and early 1980s, the origins of congenital heart disease (CHD) interventional fellowship training can be traced to five seminal pioneers: Charles Mullins, James Lock, William E. Hellenbrand, Lee N. Benson, and Albert P. Rocchini. The vast majority of CHD interventional cardiologists with formal training can trace their learning lineage back to this group. In the video, listen to William E. Hellenbrand, MD, MSCAI; Lee N. Benson, MD, MSCAI; Albert P. Rocchini, MD; and Frank F. Ing, MD, MSCAI, as they discuss how each of their programs began. The accompanying article in JSCAI features tributes to each of the five pioneers, written by their former fellows. Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2025.103707
Sandeep Nathan, MD, MSc, FACC, FSCAI, Matthew Sherwood, MD, FSCAI, Kendra Grubb, MD, Adam Greenbaum, MD, FSCAI discuss the SCAI Expert Consensus Statement published in JSCAI. The panel provides an insightful overview of the expert consensus, highlighting that alternative access is essential for a small subset of TAVR patients. It emphasizes the most effective techniques, the importance of a collaborative, multidisciplinary approach in patient selection, and the need to recognize institutional resources and operator capabilities for optimal patient outcomes. Additionally, the panel explores how cutting-edge advancements in device technology and imaging are revolutionizing the safety and precision of alternative access TAVR procedures, enhancing both patient care and procedural success.Read the article: https://doi.org/10.1016/j.jscai.2024.102514
In two landmark articles published in the JSCAI, leading experts Elazer R. Edelman, MD, PhD, Michael Taylor, MD, PhD, Brian Quinn, MD, and Kathy Jenkins, MD, MPH discuss the transformative potential of artificial intelligence (AI) in pediatric and congenital cardiac care. Read the related articles:The Role of AI in CHD and Interventions: https://doi.org/10.1016/j.jscai.2025.102567 Generating Risk Reduction Analytics in Complex Cardiac Care Environments: https://doi.org/10.1016/j.jscai.2024.102434
Yiannis Chatzizisis, MD, PhD, FSCAI, Zain Khalpey, MD, PhD, FACS, Robert Herman, and Karley B. Fischer, MD discuss 4 articles published in JSCAIs special issue on "The Role of Artificial Intelligence in Cardiovascular Interventions". Watch the video conversation on AI and Coronary procedural planning and read the related articles below: Enhancing Diagnostic Accuracy and Procedural Outcomes in Interventional Cardiology Through Machine Learning Algorithms: https://doi.org/10.1016/j.jscai.2024.102511 AI in Coronary Artery Interventions: Preprocedural Planning and Procedural Assistance: https://doi.org/10.1016/j.jscai.2024.102519 Artificial Intelligence-Powered Electrocardiogram Detecting Culprit Vessel Blood Flow Abnormality: AI-ECG TIMI Study Design and Rationale: https://doi.org/10.1016/j.jscai.2024.102494 Effects of Artificial Intelligence Clinical Decision Support Tools on Complications Following Percutaneous Coronary Intervention: https://doi.org/10.1016/j.jscai.2024.102497
Jonathon Leipsic, Yader Sandoval, Koen Nieman, Natalia Pinilla, and Hector Garcia discussed the significance & highlights from the CCTA roundtable document. The panel emphasized the use of CCTA to enhance pre-procedural planning, improve patient outcomes, and optimize resource utilization by providing detailed anatomical and functional assessments of coronary lesions. The experts also highlighted the roundtable's recommendations, which included increasing access to contemporary CCTA scanners, enhancing visualization tools for interventionalists, and promoting educational training efforts. Read the article: https://doi.org/10.1016/j.jscai.2025.103664
Elazar Edelman, MD, PhD, Rohan Khera MD, MS, Afnan Tariq, MD, JD, FSCAI, & Curtis Rooney discuss 2 articles published in JSCAI's latest issue. This video interview focuses on its role in optimizing patient care, preserving physician autonomy, and addressing algorithmic bias. The panel also dives into the ethical, regulatory, and practical considerations of AI integration, highlighting the importance of societies in advocating for education and promoting transparent, equitable, and secure AI-driven decision-making systems.1- Harnessing Artificial Intelligence for Innovation in Interventional Cardiovascular Care: https://doi.org/10.1016/j.jscai.2025.102562 2- Governing the Unbound: SCAI’s Role in the Future of Artificial Intelligence: https://doi.org/10.1016/j.jscai.2024.102517Read the special issue:
Andrew Goldsweig, Daniel Snyder, Sahil Parikh, and Herb Aronow discuss the highlights from an original research paper published in JSCAI. The study aimed to evaluate the association between intravascular ultrasound (IVUS) use and 1-year outcomes after infrapopliteal intervention. The authors found that IVUS utilization significantly reduced rates of binary restenosis and target lesion revascularization compared to angiography alone, without affecting rates of amputation, major adverse limb events, or mortality. Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2024.102509
Yiannis Chatzizisis, Maryam Alsharqi, Evan Shlofmitz, Daniel Chamié discuss three important papers published in the JSCAI special issue. The panel explores advancements in intravascular imaging (IVI) technologies, the latest research, the current landscape of AI applications, and the educational needs to bridge practice gaps. The discussion highlights how AI-driven tools can be leveraged for PCI planning, including lesion assessment, procedural optimization, and workflow efficiency to enhance patient outcomes.1- Artificial Intelligence in Cardiovascular Imaging and Interventional Cardiology: Emerging Trends and Clinical Implications: https://doi.org/10.1016/j.jscai.2024.1025582- Artificial Intelligence in Intravascular Imaging for Percutaneous Coronary Interventions: A New Era of Precision: https://doi.org/10.1016/j.jscai.2024.102506 3-Can AI Capture and Quantify Clinical Expertise? Implications for Intracoronary Imaging in Percutaneous Coronary Intervention: https://doi.org/10.1016/j.jscai.2024.102523Read the issue: https://www.jscai.org/issue/S2772-9303(25)X0003-X
Discover the latest in transcatheter correction for sinus venosus defects. The authors innovative approach utilizes balloon-expandable covered stents across the cavoatrial junction to effectively redirect the anomalous right upper pulmonary vein to the left atrium. Drs. Frank Ing, Kothandam Sivakumar, Eric Rosenthal, and Shakeel Qureshi discuss the highlights from the case series. Read the article: https://doi.org/10.1016/j.jscai.2024.102501
APEX-AV trial evaluated the safety and efficacy of the AlphaVac F1885 System for treating acute intermediate-risk pulmonary embolism (PE). The study found significant reductions in the right ventricular/left ventricular diameter ratio and pulmonary arterial pressure within 48 hours post-procedure, along with a 35.5% mean reduction in clot burden. The treatment demonstrated a low rate of major adverse events, primarily minor access site bleeding. Drs. Sahil Parikh, Mona Ranade, William Brent Keeling, and Kenneth Rosenfield discuss the trial highlights in this video interview. Read the article: https://doi.org/10.1016/j.jscai.2024.102463
SCAI Leaders—Dr. David Rizik, Dr. James Hermiller, Dr. Andrew Klein, and Dr. Islam Abudayyeh—explore the significant hazards faced by interventional cardiologists in the catheterization lab (CCL), including radiation exposure, orthopedic injuries, and the physical and psychological stress associated with the profession. They also emphasize the moral imperative to improve workplace safety, advocating for systemic changes that prioritize physician well-being, enhance long-term career sustainability, and ultimately improve patient care.Read the related JSCAI article: https://doi.org/10.1016/j.jscai.2024.102493
In this discussion, Suzanne Baron, MD, FSCAI, Zach Gertz, MD, Gregg W. Stone, MD, MSCAI, and Lissa Sugeng, MD, FSCAI, highlight key findings from the JSCAI article on the impact of forward flow in heart failure (HF) patients undergoing mitral transcatheter edge-to-edge repair (TEER). The panel discusses data from the COAPT trial, which stratified patients by baseline forward flow and assessed outcomes with TEER plus guideline-directed medical therapy (GDMT) versus GDMT alone. Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2025.102609
The clinical presentation and epidemiology of infective endocarditis (IE) have evolved over time. While the cornerstones of IE treatment remain antimicrobial therapy and surgery, percutaneous mechanical aspiration (PMA) has emerged as an option for carefully selected patients as a complementary modality, based on retrospective data, case series, and expert experience. In this comprehensive review, published in JSCAI, the authors summarize the proceedings from an inaugural summit dedicated to the discussion of PMA in the global management of IE, consisting of experts across multiple disciplines from diverse geographic regions and care environments. This video conversation highlights the comprehensive review with a panel discussion featuring Cindy Grines, MD, MSCAI, Lucas Marinacci, MD, Kenneth Rosenfield, MD, MSc, MSCAI, & Molly Paras, MD.Read the article: https://doi.org/10.1016/j.jscai.2024.102283
The video panel discussion featuring Cindy Grines, MD, MSCAI, Revathy Sampath-Kumar, MD, Ian Gilchrist, MD, MSCAI, Michel Le May, BSc, MD, and Pradyumna Tummala, MD highlights the findings of the study published in JSCAI. The study found that radial to femoral access-site crossover (RFC) during percutaneous coronary intervention (PCI) was associated with higher short-term mortality and bleeding complications compared to radial access (RA). Independent predictors of RFC included age greater than 70 years, vasopressor support, and dialysis dependence. Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2024.102450
Comments
Download from Google Play
Download from App Store
United States